The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Oct. 21, 2013
Applicant:

The University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Peter Wipf, Pittsburgh, PA (US);

Jingbo Xiao, Pittsburgh, PA (US);

Mitchell P. Fink, Pittsburgh, PA (US);

Valerian Kagan, Pittsburgh, PA (US);

Yulia Tyurina, Pittsburgh, PA (US);

Anthony J. Kanai, Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); C07K 5/10 (2006.01); A61K 31/555 (2006.01); A61K 31/7034 (2006.01); A61K 31/7048 (2006.01); A61K 47/48 (2006.01); C07K 5/08 (2006.01);
U.S. Cl.
CPC ...
C07K 5/10 (2013.01); C07K 7/06 (2013.01); A61K 31/555 (2013.01); A61K 31/7034 (2013.01); A61K 31/7048 (2013.01); A61K 47/481 (2013.01); A61K 47/48246 (2013.01); C07K 5/08 (2013.01);
Abstract

The present invention provides a composition and related methods for delivering cargo to a mitochondria which includes (a) a membrane active peptidyl fragment having a high affinity with the mitochondria and (b) cargo. The cargo may be selected from a wide variety of desired cargoes which are to be delivered to the mitochondria for a specific purpose. Compositions and methods are disclosed for treating an illness that is caused or associated with cellular damage or dysfunction which is caused by excessive mitochondrial production of reaction oxygen species (ROS). Compositions which act as mitochondria-selective targeting agents using the structural signaling of the β-turn recognizable by cells as mitochondria) targeting sequences are discussed. Mitochondria and cell death by way of apoptosis is inhibited as a result of the ROS-scavenging activity, thereby increasing the survival rate of the patient.


Find Patent Forward Citations

Loading…